Complementary Medication for COVID-19 Outbreak Concerns in the Leprosy Community - A Passionate Proposal

Abstract

Abstract: The number of COVID-19-positive cases continues to climb, causing alarm around the world. The Nilavembu (Andrographis paniculata) Kudineer of Siddha medicine, an alternative medicine practiced in India, has already been shown to be beneficial in viral outbreaks like Chikungunya and Dengue fever. Several investigations have demonstrated that these herbs have anti-inflammatory, analgesic, antipyretic, antibacterial, and antiviral activities against the Herpes simplex virus and Ebstein Barr virus. This herbal remedy has also been shown to have a low risk of negative side effects. There is currently no approved pharmaceutical treatment for COVID-19. Using the phrases 'COVID-19,' 'Ayush,' 'Siddha,' and 'Leprosy,' we searched other databases such as Google, Embase, ScienceDirect, and the Clinical Trial Registry of India. In another research on Siddha treatment, Kabasura Kudineer, a decoction of 15 herbal items was discovered to have activity against the spike protein of SARS COV-2 using an in-silico compound method. As there are no effective treatments available for the prevention and treatment of mild to moderate cases, these two medicines, Nilavembu Kudineer, and Kabasura Kudineer can be used as part of a COVID-19 prophylaxis using a combination of modern and alternative medicine.